KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Inventory (2016 - 2025)

LifeMD filings provide 14 years of Inventory readings, the most recent being $2.8 million for Q4 2025.

  • On a quarterly basis, Inventory fell 0.85% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 0.85% decrease, with the full-year FY2025 number at $2.8 million, down 0.85% from a year prior.
  • Inventory hit $2.8 million in Q4 2025 for LifeMD, down from $3.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $3.8 million in Q3 2023 to a low of $1.2 million in Q1 2022.
  • Median Inventory over the past 5 years was $2.8 million (2024), compared with a mean of $2.7 million.
  • Biggest five-year swings in Inventory: soared 202.08% in 2021 and later tumbled 44.28% in 2024.
  • LifeMD's Inventory stood at $1.6 million in 2021, then surged by 129.08% to $3.7 million in 2022, then fell by 25.47% to $2.8 million in 2023, then increased by 1.36% to $2.8 million in 2024, then decreased by 0.85% to $2.8 million in 2025.
  • The last three reported values for Inventory were $2.8 million (Q4 2025), $3.4 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.